Severin Schwan and Thomas Schinecker (Roche)

Af­ter 14 years as Roche’s CEO, Sev­erin Schwan is pass­ing the ba­ton

Roche CEO Sev­erin Schwan will be mov­ing to the board chair­man role in a few months, mak­ing room for Thomas Schi­neck­er — the cur­rent chief of the di­ag­nos­tics di­vi­sion — to take the helm of the Swiss phar­ma con­glom­er­ate.

The changeover will take place at the com­pa­ny’s an­nu­al gen­er­al meet­ing in March as Christoph Franz, chair­man since 2014, de­cid­ed not to seek re-elec­tion to the board.

The shuf­fle at the top comes as Roche has steadi­ly beefed up its ear­ly-stage pipeline while vig­i­lant­ly guard­ing its po­si­tion as one of the top drug­mak­ers around the world. By Eval­u­ate’s es­ti­mate, it is set to rank sec­ond on the list of largest phar­mas by 2028, falling just a tad be­hind Ab­b­Vie.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.